CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Clinical Review
Treatment Approach to Patients with Combined Peripheral and Coronary Artery Disease
Abstract
Atherothrombotic disease is one of the leading causes of mortality across the globe. A significant percentage of patients have a combined involvement of more than one vascular bed at the same time, which has a substantial effect on cardiovascular outcomes. Peripheral arterial disease is often underdiagnosed, especially in patients with coronary artery disease. This article reviews the approach to patients with combined peripheral and coronary artery disease and highlights the importance of identifying the presence of combined disease, their risk factors, diagnosis
Percutaneous Mitral Valve Interventions: Overview of New Approaches
Abstract Percutaneous therapy has emerged over the past few years as a rapidly progressing field of development for the treatment of mitral regurgitation. Most of the new percutaneous approaches are modifications of previously-described surgical techniques that have been used for mitral valve repair for several decades. The main surgical approaches to mitral valve repair are annuloplasty and leaflet repair. Catheter-based devices mimic these surgical approaches with the aim of achieving outcomes similar to surgery, with less procedural morbidity and mortality as
Nitrous Oxide Sedation-Analgesia in a Phlebology Practice
“Since the operation the patient…expresses a strong affection for the gas-bag, and an earnest desire to retain it in his possession as the grand balm for the pains and trouble of this life.”1 — 1847 advertisement
Phlebology has become primarily an office-based specialty thanks in no small part to the success of minimally invasive procedures, such as endovenous catheter ablation and microincisional ambulatory phlebectomy done under tumescent local anesthesia, which have largely replaced traditional vein stripping done under general anesthesia. Tumescent a
Bare-Stent Technology and Its Utilization in the Treatment of Atherosclerotic Obstructive Disease
Abstract
Following the introduction of percutaneous angioplasty (PTA), arterial stents emerged as a tool for preventing the acute arterial wall recoil and chronic restenosis associated with PTA. The use of stents has grown considerably in the last decade. There is a wide spectrum of clinical applications for the use of stents in the arterial vascular system, but every vascular territory demands specific stent adaptations such as resistance to kink and fracture in the femoropopliteal segment or high radial force in aortic ostial lesions. This article discusses the different type
Venous Laser Updates: New Wavelength or New Fibers?
Introduction
Since the introduction of endovenous lasers (EVL) in the early 2000s, procedure methodologies, as well as device technologies, have evolved extensively in the endeavor to improve treatment outcomes. As each novel parameter has been studied, new data have enabled the venous ablation community to acquire an enhanced understanding of the laser’s mechanism of action. The primary subject matter in EVL studies has routinely included one or a combination of the following: laser fiber vein-wall contact,1,2 linear endovenous energy density (LEED), &nb
Cardiogenic Shock: From Reperfusion to Revascularization and Hemodynamic Support
Amar R. Chadaga, MD, Jamil B. Dihu, MD, Timothy A. Sanborn, MD
Abstract
Cardiogenic shock represents the most ominous challenge of acute myocardial infarction (AMI), with an incidence of 8–9% and a mortality rate approaching 50%. The majority of cases of cardiogenic shock are secondary to AMI complicated by left ventricular failure leading to refractory hypoperfusion and hypotension. Placement of an intra-aortic balloon pump (IABP) and primary percutaneous coronary intervention (PCI), particularly in young patients, remain the America
Management of Common Femoral Artery and Bifurcation Diseases
pg. E27 - E30
__________________________
Introduction and Epidemiology
Isolated atherosclerotic involvement of the common femoral artery (CFA) and its bifurcation are rare and reports consisting large patient series are unavailable. The CFA is usually involved as a continuum with the atherosclerosis of the proximal (iliac) or distal (femoro-popliteal) arterial segments. CFA and its bifurcation are critical segments of the lower-limb arterial tree, exemplified by the development of acute and limb-threatening ischemia when it is occluded with a thrombotic or thrombo-
Impact of Technique and Device Selection on Clinical Outcomes in Carotid Artery Stenting
pg. E20 - E26
_________________________
Introduction
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths.1 Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.2 Almost 20% of ischemic strokes result from carotid artery stenosis.3,4 Various options for the management of carotid artery stenosis include medical therapy, carotid artery endarterectomy (CEA) and carotid artery stenting (CAS). CEA has been established as a gold-standard treatment for ca
Intracranial Stent-assisted Revascularization for Acute Ischemic Stroke
From *University at Buffalo, State University of New York, Buffalo, New York and §Millard Fillmore Gates Hospital, Kaleida Health; Departments of Neurosurgery & Radiology and Toshiba Stroke Research Center, Buffalo, New York.
Manuscript submitted July 29, 2009, provisional acceptance given August 17, 2009, accepted September 9, 2009.
Correspondence: L. Nelson Hopkins, MD, University at Buffalo, State University of New York, Neurosurgery, 3 Gates Circle, Buffalo, NY 14209. E-mail: lnhbuffns@aol.com
Disclosures: Dr. Hopkins receives research support from Toshiba; serves as a consultant
IVC Filters: Indications and Evidence
Abstract
The role of anticoagulants in the treatment of venous thrombo-embolic disease is well established. The use of inferior vena cava filters as a second line treatment is increasing, most recently with the popularity of of retrievable filters. However, the indications and evidence for their safety and efficacy are not clear-cut. There are few absolute indications. The majority of evidence originates from single-center series studying a preferred few genres of filters. Generalizability and meta-analysis are difficult. Important questions remain to be answered, particularly regard
Vascular Disease Blogs
Frank J. Criado, MD, FACS, FSVM
Robert S. Dieter, MD, RVT and Aravinda Nanjundappa, MD, RVT
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Tuesday, August 31, 2010 - 13:44
- Tuesday, August 31, 2010 - 13:41
- Tuesday, August 31, 2010 - 13:37
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
